Skip Navigation LinksHome > October 2013 - Volume 33 - Issue 5 > α1-Adrenergic Receptors Contribute to the Acute Effects of 3...
Journal of Clinical Psychopharmacology:
doi: 10.1097/JCP.0b013e3182979d32
Original Contributions

α1-Adrenergic Receptors Contribute to the Acute Effects of 3,4-Methylenedioxymethamphetamine in Humans

Hysek, Cédric M. PhD*; Fink, Anja E. MD*; Simmler, Linda D. PhD*; Donzelli, Massimiliano MSc*; Grouzmann, Eric PhD; Liechti, Matthias E. MD, MAS*

Supplemental Author Material
Collapse Box

Abstract

Preclinical studies implicate a role for α1-noradrenergic receptors in the effects of psychostimulants, including 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”). The present study evaluated the effects of the α1-noradrenergic receptor antagonist doxazosin on the acute pharmacodynamic and pharmacokinetic response to MDMA in 16 healthy subjects. Doxazosin (8 mg/d) or placebo was administered for 3 days before MDMA (125 mg) or placebo using a randomized, double-blind, placebo-controlled, 4-session, crossover design. Doxazosin reduced MDMA-induced elevations in blood pressure, body temperature, and moderately attenuated positive mood but enhanced tachycardia associated with MDMA. The results indicate that α1-adrenergic receptors contribute to the acute cardiostimulant and to a minor extent possibly also to the thermogenic and euphoric effects of MDMA in humans.

Copyright © 2013 by Lippincott Williams & Wilkins

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.